Portable Diagnostics GeneCapture is developing a portable RNA-based infection diagnostic capable of screening hundreds of pathogens within an hour for under $20, presenting a compelling value proposition for rapid, on-site disease detection at hospitals, airports, ships, and field operations.

Point of Care Upsell The focus on Point of Care testing creates sales opportunities with healthcare facilities, travel hubs, military logistics, and emergency response teams seeking fast, decentralized testing solutions that reduce turnaround times and improve patient flow.

Tech-Driven Differentiation CAPTURE technology, unamplified RNA expression-based detection, differentiates GeneCapture in a crowded diagnostics market, enabling partnerships around rapid screening devices and integration with existing clinical workflows.

Strategic Partnerships GeneCapture’s residency at HudsonAlpha and prior accelerator recognition suggest openness to collaborations; target system integrators, hospital networks, and defense or aviation contractors to co-develop and deploy portable diagnostic solutions.

Growth Readiness With a revenue range of $10M-$25M and a small-to-mid sized employee base, there is opportunity to scale through pilots, clinical validation programs, and regulatory-ready instrument deployments with partners who can fund and distribute at scale.